Taken together, the CD11b expression, the NBT reduction tests, the morphologic changes, and the myeloid regulator expression changes clearly suggest that the combination of TAK165 and ATRA to induce myeloid differentiation of AML cells has great potential. The gene discussed is ITGAM; the disease is acute myeloid leukemia.